Atossa Therapeutics Stock (NASDAQ: ATOS) stock price, news, charts, stock research, profile.
You can purchase shares of Atossa Therapeutics (NASDAQ:ATOS) through any online brokerage.
Other companies in Atossa Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Cabaletta Bio (NASDAQ:CABA), Invizyne Technologies (NASDAQ:IZTC) and Aligos Therapeutics (NASDAQ:ALGS).
Atossa Therapeutics has a consensus price target of $7.00.
The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $0.8312 last updated January 17, 2025 at 7:57 PM EST.
There are no upcoming dividends for Atossa Therapeutics.
Atossa Therapeutics’s Q4 earnings are confirmed for Monday, March 31, 2025.
There is no upcoming split for Atossa Therapeutics.
Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.